Proactive Management of Adverse Effects Associated With Waldenström Macroglobulinemia | PTCE Pharmacy Connect

Educational Objective
Identify best practices for managing toxicities associated with therapies for the treatment of Waldenström macroglobulinemia
 
Faculty: Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan

Faculty has no financial relationships with commercial interests to disclose.




Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-457-H01-P. The activity is available for CE credit through June 20, 2022.

This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices